These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


131 related items for PubMed ID: 24751674

  • 1. Gene delivery to carcinoma cells via novel non-viral vectors: nanoparticle tracking analysis and suicide gene therapy.
    Gebremedhin S, Singh A, Koons S, Bernt W, Konopka K, Duzgunes N.
    Eur J Pharm Sci; 2014 Aug 18; 60():72-9. PubMed ID: 24751674
    [Abstract] [Full Text] [Related]

  • 2. Serum decreases the size of Metafectene-and Genejammer-DNA complexes but does not affect significantly their transfection activity in SCCVII murine squamous cell carcinoma cells.
    Konopka K, Overlid N, Nagaraj AC, Düzgüneş N.
    Cell Mol Biol Lett; 2006 Aug 18; 11(2):171-90. PubMed ID: 16847564
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Suicide gene therapy using adenovirus vector for human oral squamous carcinoma cell line in vitro.
    Yamamoto N, Hayashi Y, Kagami H, Fukui T, Fukuhara H, Tohnai I, Ueda M, Mizuno M, Yoshida J.
    Nagoya J Med Sci; 2005 Jun 18; 67(3-4):83-91. PubMed ID: 17375474
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Combine cancer gene therapy harnessing plasmids expressing human tumor necrosis factor alpha and Herpes simplex thymidine kinase suicide gene.
    Pastorakova A, Hlubinova K, Jakubikova J, Altaner C.
    Neoplasma; 2006 Jun 18; 53(5):353-62. PubMed ID: 17013529
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Photochemically enhanced gene transfection increases the cytotoxicity of the herpes simplex virus thymidine kinase gene combined with ganciclovir.
    Prasmickaite L, Høgset A, Olsen VM, Kaalhus O, Mikalsen SO, Berg K.
    Cancer Gene Ther; 2004 Jul 18; 11(7):514-23. PubMed ID: 15118758
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Delivery of herpes simplex thymidine kinase bystander effect by engineered human mesothelial cells for the treatment of ovarian cancer.
    Rancourt C, Bergeron C, Lane D, Garon G, Piché A.
    Cytotherapy; 2003 Jul 18; 5(6):509-22. PubMed ID: 14660047
    [Abstract] [Full Text] [Related]

  • 16. Adenoviral-mediated delivery of the herpes simplex virus thymidine kinase gene selectively sensitizes human ovarian carcinoma cells to ganciclovir.
    Rosenfeld ME, Feng M, Michael SI, Siegal GP, Alvarez RD, Curiel DT.
    Clin Cancer Res; 1995 Dec 18; 1(12):1571-80. PubMed ID: 9815958
    [Abstract] [Full Text] [Related]

  • 17. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D, Vogels R, Havenga M, Avezaat CJ, Bout A, Smitt PS.
    Cancer Res; 2001 Dec 15; 61(24):8743-50. PubMed ID: 11751394
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.